Skip to main content
. Author manuscript; available in PMC: 2014 May 12.
Published in final edited form as: Biopharm Drug Dispos. 2013 Sep 12;34(8):442–451. doi: 10.1002/bdd.1860

Table 1.

Cyclosporine and Tacrolimus Dose and AUC (weight and dose normalized) for Weeks 2 –12 and 28–104 (data reported as median or median [IQR]) compared to nonHIV transplant (tx)

CsA wks 2–12 wks 28–104
n* Dose
(mg/kg)
AUC
(ng*hr/mL/mg/kg)
n* Dose
(mg/kg)
AUC
(ng*hr/mL/mg/kg)
nonHIV tx 55 4 7000–9000 55 2 4500–6000
+PI 34 0.36 5759 [3325–8045] 16 0.34 5603 [3867–6658]
+EFV 18 4.03 862 [744–1131] 4 1.74 1201 [992–1422]
+NVP 18 2.21 1945 [1585–3277] 21 1.47 1905 [1486–2557]
+PI +EFV 3 4.03 10290 [8887–13778] N/A N/A N/A
+PI +NVP 10 0.50 6718 [3933–7941] 10 0.63 5007 [3281–9168]
TAC wks 2–12 wks 28–104
n* Dose
(mg/kg)
AUC
(ng*hr/mL/mg/kg)
n* Dose
(mg/kg)
AUC
(ng*hr/mL/mg/kg)
nonHIV tx 44 0.10 2000–5000 44 0.15 2000–5000
+PI 8 0.007 24996 [18205–41601] 3 0.003 34653 [17208–42250]
+EFV 3 0.058 2170 [936–3261] 4 0.046 1911 [1423–3071]
+NVP 5 0.021 3644 [3115–5157] 6 0.029 4220 [2703–6229]
*

number of PK studies

from ref [18].